Ibex's Galen AI pathology analysis software gets FDA nod

2018 08 28 18 59 9066 Artificial Intelligence Ai 400

The U.S. Food and Drug Administration (FDA) has designated Ibex Medical Analytics' Galen artificial intelligence (AI) software for pathology image analysis as a breakthrough device. The designation is granted to technologies with the potential to better diagnose cancer.

The AI-powered software supports pathologists in the detection of various types of cancer. Galen aims to reduce diagnosis time and boost productivity.

Page 1 of 162
Next Page